117 related articles for article (PubMed ID: 36480751)
1. Gastric cancer: histological response of tumor and metastatic lymph nodes for perioperative chemotherapy.
Fonseca T; Coimbra M; Barbosa E; Barbosa J
Cir Cir; 2022; 90(S2):36-41. PubMed ID: 36480751
[TBL] [Abstract][Full Text] [Related]
2. MORBIDITY AND SURVIVAL AFTER PERIOPERATIVE CHEMOTHERAPY IN GASTRIC CANCER: A STUDY USING THE BECKER'S CLASSIFICATION AND REGRESSION.
Machado MCA; Barbosa JPCVL; Oliveira FF; Barbosa JAL
Arq Bras Cir Dig; 2023; 35():e1704. PubMed ID: 36629685
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and preliminary application of tissue response grading system following neoadjuvant chemotherapy].
Yang K; Zhang W; Chen X; Chen X; Liu K; Zhao L; Liu J; Wu B; Zhou Z; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1032-1038. PubMed ID: 30269324
[TBL] [Abstract][Full Text] [Related]
4. Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer.
Cabral F; Ramos P; Monteiro C; Casaca R; Pinto I; Abecasis N
Cir Esp (Engl Ed); 2021; 99(7):521-526. PubMed ID: 34353591
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.
Mingol F; Gallego J; Orduña A; Martinez-Blasco A; Sola-Vera J; Moya P; Morcillo MA; Ruiz JA; Calpena R; Lacueva FJ
BMC Surg; 2015 May; 15():66. PubMed ID: 25997454
[TBL] [Abstract][Full Text] [Related]
6. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
7. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
8. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
9. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
10. Short-term curative effect of S-1 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer: a prospective comparison study.
Zhao Q; Li Y; Huang J; Fan L; Tan B; Tian Y; Yang P; Jiao Z; Zhao X; Zhang Z; Wang D; Liu Y
Pharmazie; 2017 Apr; 72(4):236-240. PubMed ID: 29441995
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].
Jin J; Deng J; Liang H; Sun C; Guo X; Guo J; Bai H; Liu H; Zhang N
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):53-60. PubMed ID: 29354900
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
15. The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer.
Kim YJ; Chung WC; Youn GJ; Jun KH; Chin HM
Rev Esp Enferm Dig; 2019 Jul; 111(7):537-542. PubMed ID: 31215209
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.
Yamao T; Ohta K; Ohyama S; Ishihara S; Chin K; Maruyama M; Takahashi T; Nakajima T
Jpn J Clin Oncol; 2004 May; 34(5):255-61. PubMed ID: 15231860
[TBL] [Abstract][Full Text] [Related]
17. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
18. [Short-term efficacy evaluation of laparoscopic spleen-preserving splenic hilus lymphadenectomy and left epigastrium mesogastric excision for advanced proximal gastric cancer based on mesangial anatomy].
Zhang YF; Chen P; Sun JG; Fan XJ; Wang YM; Gao YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):177-182. PubMed ID: 32074799
[No Abstract] [Full Text] [Related]
19. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
20. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma.
Pardo F; Osorio J; Miranda C; Castro S; Miró M; Luna A; Garsot E; Momblán D; Galofré G; Rodríguez-Santiago J; Pera M;
Clin Transl Oncol; 2020 Aug; 22(8):1335-1344. PubMed ID: 31865605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
